Sepio Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$990K Buy
826
+45
+6% +$46K 0.05% 165
2026
Q1
$718K Sell
781
-64
-8% -$64.9K 0.04% 211
2025
Q4
$908K Buy
845
+136
+19% +$130K 0.05% 177
2025
Q3
$541K Buy
+709
New +$528K 0.03% 210
2024
Q4
Sell
-288
Closed -$255K 304
2024
Q3
$255K Buy
+288
New +$259K 0.02% 272
2024
Q1
Sell
-500
Closed -$291K 296
2023
Q4
$291K Buy
+500
New +$292K 0.02% 253
2023
Q1
Sell
-568
Closed -$208K 355
2022
Q4
$208K Sell
568
-129
-19% -$45.7K 0.02% 324
2022
Q3
$228K Buy
697
+40
+6% +$12.7K 0.02% 300
2022
Q2
$213K Buy
+657
New +$197K 0.02% 315

Other funds holding LLY

Sepio Capital's LLY Position: Q2 2026 in Review

Sepio Capital increased its Eli Lilly (LLY) stake by 5.8% in Q2 2026, buying an estimated $46K and bringing the position to 826 shares worth $990K. The position accounts for 0.05% of the portfolio, ranked #165.

Sepio Capital first reported a position in LLY in Q2 2022 and has held it in 9 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Sepio Capital held 826 shares of Eli Lilly worth $990K as of Q2 2026.
  • Sepio Capital bought 45 Eli Lilly shares in Q2 2026, an estimated $46K.
  • Eli Lilly made up 0.05% of Sepio Capital's portfolio in Q2 2026, its #165 holding.
  • Sepio Capital first reported a position in Eli Lilly in Q2 2022 and has held it in 9 quarters since.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Sepio Capital's 13F filing for Q2 2026, filed 28 Jul 2026.